Director
AbbVie, Illinois
Qin Ji, Ph.D., currently is a director in the department of Quantitative, Translational & ADME Sciences (QTAS) at AbbVie. He leads an Integrated Sciences Team (IST) for endogenous molecule and custom bioanalysis for in vivo and in vitro studies, and for translational research. He also serves as the QTAS area lead for biomarker bioanalysis for oncology programs at Abbvie. Prior to that, Qin held scientific and management positions including Research Fellow at Bristol-Mayes Squibb, Senior Director of Bioanalytical Chemistry at Covance Laboratories, and Associate Research Fellow in the prestigious Volwiler Scientific Society at Abbott Laboratories. He has authored/co-authored more than 80 peer reviewed scientific publications, 5 book chapters, and co-edited 2 books. Qin obtained two President Awards while he was at Abbott Laboratories. He received a Chemistry Leadership Award and a prestigious James B.D. Palmer Award for Excellence in Drug Development when he was at BMS. Qin has served as session chairs and (or) invited speakers at scientific conferences including ASMS, Land O’ Lakes bioanalytical conference, WRIB, and US FDA/AAPS Crystal City workshop.
Keynote: New Era of Bioanalysis Post Covid-19 Pandemic
Tuesday, October 24, 2023
1:30 PM – 2:30 PM ET